Literature DB >> 29785323

Coexistence of urticaria pigmentosa and thalassemia minor in a young adult.

Funda Tamer1, Haldun Umudum2.   

Abstract

Entities:  

Keywords:  mastocytosis; thalassemia; urticaria pigmentosa; young adult

Year:  2018        PMID: 29785323      PMCID: PMC5955073          DOI: 10.5826/dpc.0802a03

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


× No keyword cloud information.
An 18-year-old Caucasian patient presented with an asymptomatic skin eruption on his trunk. The patient stated the lesions have been present for 15 years and that the lesions were more prominent and more extensive in childhood. However, the size and number of lesions decreased with time. The past medical history was remarkable for beta thalassemia minor. He had not received any treatment for the skin lesions or thalassemia previously. Dermatologic examination revealed erythematous, hyperpigmented papules and plaques on the neck, chest and upper back (Figure 1). Darier sign was present. A skin biopsy was performed to reach a definitive diagnosis. Histopathologic evaluation revealed a massive mast cell infiltration and eosinophils in the dermis (Figure 2). The diagnosis of urticaria pigmentosa was made based on clinical and histopathologic features. Laboratory tests, including complete blood count, chemistry panel, complete urinalysis, thyroid-stimulating hormone (TSH), serum iron, iron-binding capacity, ferritin, folate, vitamin B12, sedimentation, C-reactive protein (CRP) and abdominal ultrasonography were performed to rule out systemic involvement. The chemistry panel, urine test, TSH, serum iron, iron-binding capacity, ferritin, folate, vitamin B12, sedimentation, CRP and abdominal ultrasonography were all within normal limits. The complete blood count was normal except for slightly decreased mean platelet volume (5.98 fL, range: 6.4–11 fL) and slightly elevated eosinophil percentage (7.8%, range: 0%–7%). Unfortunately, further diagnostic tests such as serum tryptase level, tryptase in bone marrow blood, histamine and metabolites in a 24-hour urine analysis were not performed. The patient refused bone marrow biopsy due to fear of pain. Therefore, the patient was informed about the triggers of mast cell activation and it was recommended to him that he make regular follow-up appointments.
Figure 1

(a) Hyperpigmented papules on the neck and chest. Urticarial plaque indicates a positive Darier’s sign. (b) Hyperpigmented macules and papules on the upper back. [Copyright: ©2018 Tamer et al.]

Figure 2

(a) Dense mast cell infiltration with some eosinophils in the dermis (H&E ×40). (b) Numerous mast cells in the dermis (metachromatic staining with toluidine blue ×100). [Copyright: ©2018 Tamer et al.]

Urticaria pigmentosa is a form of cutaneous mastocytosis that is characterized by excessive mast cell infiltration of the superficial dermis [1]. It presents with hyperpigmented macules, papules or nodules on the trunk and extremities [2]. Thalassemia minor is a common genetic disorder that is characterized by a mutation in one chain of β-globin for hemoglobin. The patients with thalassemia minor are usually asymptomatic. Blood tests may reveal mild anemia or normal hemoglobin levels [3]. Urticaria pigmentosa may progress to systemic mastocytosis in 4.5%–10% of cases [1]. Systemic involvement is more common in adults than in children [1]. In these patients, increased histamine levels due to mast cell proliferation can lead to diarrhea, bronchospasm, arthralgia, weight loss, and flushing [2]. Elevated serum tryptase level, peripheral blood eosinophilia, skin biopsy, biopsy of the suspected involved organ such as colon or liver, KIT D816V mutation, CD2 and CD25 expression of the bone marrow or affected tissue may be helpful in the diagnosis of systemic mastocytosis in adults [4]. Furthermore, Proelss et al suggest that elevated levels of tryptase in the bone marrow may be a sensitive marker of systemic mastocytosis [5]. Urticaria pigmentosa may be associated with hematologic abnormalities and malignancies. Ogg et al reported a 44-year-old male with an eight-year history of urticaria pigmentosa who developed multiple myeloma and renal failure [2]. Jappe et al reported on a 5-year-old male with urticaria pigmentosa and thrombocytosis. They suggest that thrombocytosis may precede systemic mastocytosis [1]. Other diseases that coexist with urticaria pigmentosa are polycythemia vera [6], acute lymphoblastic leukemia [7], and massive peripheral eosinophilia [8]. Hodgkin’s disease, lymphocytic lymphoma and chronic lymphocytic leukemia have also been associated with urticaria pigmentosa [2]. The case we described is unique in that the patient had both urticaria pigmentosa and thalassemia minor simultaneously. Thalassemia may be considered as a hematologic disorder that can occur in patients with urticaria pigmentosa. However, further studies are required to explain possible common etiological mechanisms.
  8 in total

1.  Urticaria pigmentosa coexisting with multiple myeloma.

Authors:  G S Ogg; J L Rosbotham; D M MacDonald
Journal:  Clin Exp Dermatol       Date:  1996-09       Impact factor: 3.470

2.  Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of systemic mastocytosis and Down's syndrome.

Authors:  U Lappe; V Aumann; U Mittler; H Gollnick
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-11       Impact factor: 6.166

3.  Urticaria pigmentosa with concomitant polycythaemia vera in a 3-year-old boy.

Authors:  B E K Guevara; V P Guillano; J F Dayrit
Journal:  Clin Exp Dermatol       Date:  2017-06-14       Impact factor: 3.470

Review 4.  How we diagnose and treat systemic mastocytosis in adults.

Authors:  Robyn M Scherber; Uma Borate
Journal:  Br J Haematol       Date:  2017-10-19       Impact factor: 6.998

5.  Urticaria pigmentosa presenting with massive peripheral eosinophilia.

Authors:  R L Stern; S M Manders; S H Buttress; W R Heymann
Journal:  Pediatr Dermatol       Date:  1997 Jul-Aug       Impact factor: 1.588

6.  Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.

Authors:  Julia Proelss; Joerg Wenzel; Yon Ko; Thomas Bieber; Ralf Bauer
Journal:  J Am Acad Dermatol       Date:  2006-10-30       Impact factor: 11.527

Review 7.  Thalassemia Minor and Major: Current Management.

Authors:  Ved Prakash Choudhry
Journal:  Indian J Pediatr       Date:  2017-04-24       Impact factor: 1.967

8.  Urticaria pigmentosa and acute lymphoblastic leukaemia.

Authors:  H M Lewis; E Winter; P Darbyshire; A Yoong; J R Marsden; C Moss
Journal:  J R Soc Med       Date:  1995-09       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.